https://www.selleckchem.com/pr....oducts/isoxazole-9-i
To compare the treatment approaches and disease outcomes of children with JDM followed in two European tertiary care pediatric rheumatology centers. The medical notes of patients with JDM seen at Istituto Giannina Gaslini (IGG) of Genoa, Italy or Great Ormond Street Hospital (GOSH) of London, UK between January 2000 and December 2015 within 6 months after disease onset and followed for at least 6 months were reviewed. Demographic, clinical and therapeutic data were collected. At each visit, the caring physician was asked to ra
Like
Comment
Share
